Nadia Causs News Today

The addition of bevacizumab to trifluridine and tipiracil extended OS among patients with advanced colorectal cancer, according to a topline data announcement.Trifluridine and tipiracil (Lonsurf; Taiho Oncology, Servier) is an oral agent that utilizes a dual mechanism of action to maintain clinical activity. Trifluridine, an antineoplastic nucleoside analogue, interferes with DNA function. The

Press release content from Business Wire. The AP news staff was not involved in its creation.